CAS: 2095393-15-8
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | ARQ 531 REF: TM-T14323CAS: 2095393-15-8 | 98.69% - 99.59% | 49.00 €~532.00 € | Wed 04 Dec 24 |
 | ARQ 531 REF: IN-DA01EO8ECAS: 2095393-15-8 | 99% | To inquire | Wed 04 Dec 24 |
 | ARQ 531 REF: TR-A158920CAS: 2095393-15-8 | - - - | 3,559.00 € | Tue 14 Jan 25 |
 | ARQ 531 REF: 3D-VID39315CAS: 2095393-15-8 | Min. 95% | To inquire | Wed 15 Jan 25 |
ARQ 531
CAS:2095393-15-8
ARQ-531: potent oral BTK inhibitor, anti-cancer potential, IC50 of 0.85/0.39 nM for WT/C481S-BTK.
Formula:
C25H23ClN4O4
Purity:
98.69% - 99.59%
Color and Shape:
Solid
Molecular weight:
478.93
Ref: TM-T14323
| 2mg | 49.00 € | ||
| 5mg | 87.00 € | ||
| 10mg | 126.00 € | ||
| 25mg | 209.00 € | ||
| 50mg | 333.00 € | ||
| 100mg | 532.00 € | ||
| 1mL*10mM (DMSO) | 96.00 € |
Estimated delivery in United States, on Wednesday 4 Dec 2024
Ref: IN-DA01EO8E
| 1g | To inquire | ||
| 25mg | 194.00 € | ||
| 50mg | 308.00 € | ||
| 100mg | 654.00 € | ||
| 250mg | To inquire |
Estimated delivery in United States, on Wednesday 4 Dec 2024
ARQ 531
Controlled ProductCAS:2095393-15-8
Formula:
C25H23ClN4O4
Color and Shape:
Neat
Molecular weight:
478.928
Ref: TR-A158920
| 250mg | 3,559.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
ARQ 531
CAS:2095393-15-8
ARQ 531 is a potent and selective inhibitor of the tyrosine kinase domain of c-Kit. …
Formula:
C25H23ClN4O4
Purity:
Min. 95%
Molecular weight:
478.93 g/mol
Ref: 3D-VID39315
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Wednesday 15 Jan 2025
